SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $342 | -8.3% | 12,416 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $373 | -17.1% | 12,416 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $450 | +1.6% | 12,416 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $443 | -99.9% | 12,416 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $420,000 | +17.0% | 12,416 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $359,000 | -10.5% | 12,416 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $401,000 | -17.3% | 12,416 | -25.3% | 0.00% | 0.0% |
| Q4 2021 | $485,000 | +9.5% | 16,616 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $443,000 | -13.5% | 16,616 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $512,000 | +95.4% | 16,616 | +65.9% | 0.00% | +200.0% |
| Q1 2021 | $262,000 | +4.0% | 10,016 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $252,000 | +20.6% | 10,016 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $209,000 | -56.1% | 10,016 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $476,000 | – | 20,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |